Pimavanserin for the treatment of psychosis in Parkinson’s disease

Takeaway

  • Pimavanserin (PIM) is suggested to be a safe and effective antipsychotic drug for patients with Parkinson’s disease (PD) psychosis (PDP) who have cognitive impairment, including those on cognitive-enhancing medication.

Why this matters

  • Concomitant use of PIM along with cognitive-enhancing medications can provide a wider spectrum of antipsychotic relief in patients with PDP.